Aim: Aim of the study was to evaluate [F-18] FDG imaging of head and neck t
umors using a Hybrid-PET device of the 2nd or 3rd generation. Examinations
were compared to dedicated PET and Spiral-CT. Methods: 54 patients sufferin
g from head and neck tumors were examined using dedicated PET and Hybrid-PE
T after injection of 185-350 MBq [F-18] FDG. Examinations were carried out
on the dedicated PET first followed by a scan on the Hybrid-PET. Dedicated
PET was acquired in 3D mode, Hybrid-PET was performed in list mode using an
axial filter. Reconstruction of data was performed iteratively on both, de
dicated PET and Hybrid-PET. All patients received a CT scan in multislice t
echnique. All finding have been verified by the goldstandard histology or i
n case of negative histology by follow up. Results: Using dedicated PET the
primary or recurrent lesion was correctly diagnosed in 47/48 patients, usi
ng Hybrid-PET in 46/48 patients and using CT in 25/48 patients. Metastatic
disease in cervical lymph nodes was diagnosed in 17/18 patients with dedica
ted PET, in 16/18 patients with Hybrid-PET and in 15/18 with CT. False posi
tive results with regard to lymph node metastasis were seen with one patien
t for dedicated PET and Hybrid-PET, respectively, and with 18 patients for
CT. In a total of I I patients unknown metastastic lesions were seen with d
edicated PET and with Hybrid-PET elsewhere in the body. Additional malignan
t disease other than the head and neck tumor was found in 4 patients. Concl
usion: Using Hybrid-PET for [F-18] FDG imaging reveals a loss of sensitivit
y and specificity of about 1-5% as compared to dedicated PET in head and ne
ck tumors, [F-18] FDG PET with both, dedicated PET and Hybrid-PET is superi
or to CT in the diagnosis of primary or recurrent lesions as well as in the
assessment of lymph node involvement.